For survivors of Guillain-Barré Syndrome (GBS), being discharged from the hospital is just the beginning of a long and often difficult recovery with many requiring extensive physiotherapy, mental ...
MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained benefit at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback